TY  - CONF 
AU  - López López, Rafael
PY  - 2015
SN  - 0732-183X
UR  - http://hdl.handle.net/20.500.11940/7939
LA  - eng
TI  - A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)
VL  - 33
ER  -